<p><strong>Fate Therapeutics</strong> (NASDAQ:FATE) released its Q4 earnings on Thursday, February 26, 2026 at 09:00 AM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Fate Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate of $-0.27.</p>
<p>Revenue was down $491 thousand from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.01 in the last quarter, resulting in a 2.85% drop share price change the following day.</p>
<p>Here's a look at Fate Therapeutics's past performance:</p>
<p></p><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.28</td>
<td>-0.35</td>
<td>-0.46</td>
<td>-0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.27</td>
<td>-0.29</td>
<td>-0.32</td>
<td>-0.44</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.35M</td>
<td>947K</td>
<td>1.20M</td>
<td>1.57M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.74M</td>
<td>1.91M</td>
<td>1.63M</td>
<td>1.86M</td>
</tr>
</tbody>
</table><p></p>
<p>To track all earnings releases for Fate Therapeutics visit their earnings calendar here. </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>

FATE

SBIO

IBBQ

<p>Fate Therapeutics (NASDAQ:FATE) reported its Q4 earnings on February 26, 2026, missing estimated earnings with an EPS of $-0.27, matching the estimate. Revenue decreased by $491,000 compared to the previous year. In the last quarter, the company beat EPS estimates by $0.01, leading to a 2.85% drop in share price the following day. Past performance shows fluctuations in EPS and revenue across previous quarters. For more details, visit their earnings calendar.</p>

Fate Therapeutics Q4 Earnings Summary & Key Takeaways